Versigent reported third-quarter 2026 net sales of $2.45 billion, up 7.2% year over year, but net income attributable to Versigent fell to $102 million from $109 million and diluted EPS fell to $1.41 from $1.54. The company raised the midpoint of its full-year net sales guidance and raised the upper end and midpoint of its free cash flow guidance, while tightening those ranges and its Adjusted EBITDA range.
Q3 2026 net sales of $2,450 million, up 7.2% year over year; Adjusted Net Sales Growth of approximately 1%
Diluted EPS of $1.41 vs. $1.54 a year earlier; Adjusted Diluted EPS of $1.91 vs. $1.81
Full-year 2026 net sales guidance narrowed to $9,500-$9,600 million from $9,400-$9,600 million; free cash flow guidance raised to $275-$325 million from $200-$300 million
Board declared a quarterly cash dividend of $0.13 per share, payable December 17, 2026
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Versigent PLC's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Frequently asked questions
When is Versigent's next earnings date?
Versigent has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Versigent earn last quarter?
For the quarter ended Sep 2026, Versigent reported diluted EPS of $1.41 (-6.6% year over year) on revenue of $2.45B (+11.1%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.